Does the media prefer IRTC or AVR?

In the previous week, iRhythm Technologies and iRhythm Technologies both had 5 articles in the media. iRhythm Technologies' average media sentiment score of 1.11 beat Anteris Technologies Global's score of 0.36 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor WRBY or AVR?

In the previous week, Warby Parker and Warby Parker both had 5 articles in the media. Anteris Technologies Global's average media sentiment score of 0.36 beat Warby Parker's score of 0.33 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AVR or TMDX?

In the previous week, Anteris Technologies Global had 1 more articles in the media than TransMedics Group. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.55 beat Anteris Technologies Global's score of 0.36 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TransMedics Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer AVR or AXGN?

In the previous week, Anteris Technologies Global had 3 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for AxoGen. AxoGen's average media sentiment score of 1.84 beat Anteris Technologies Global's score of 0.36 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AxoGen 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to ESTA or AVR?

In the previous week, Anteris Technologies Global had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.94 beat Anteris Technologies Global's score of 0.36 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Anteris Technologies Global (AVR) Competitors

$9.15 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$9.54 +0.39 (+4.26%)

As of 06/12/2026 05:29 PM Eastern

Compare

AVR vs. IRTC, WRBY, TMDX, AXGN, and ESTA

Should you buy Anteris Technologies Global stock or one of its competitors? MarketBeat compares Anteris Technologies Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Anteris Technologies Global include iRhythm Technologies (IRTC), Warby Parker (WRBY), TransMedics Group (TMDX), AxoGen (AXGN), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

How does Anteris Technologies Global compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Anteris Technologies Global (NASDAQ:AVR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

iRhythm Technologies has higher revenue and earnings than Anteris Technologies Global. iRhythm Technologies is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.00	-$44.55M	-$0.86	N/A
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A

iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market.

In the previous week, iRhythm Technologies and iRhythm Technologies both had 5 articles in the media. iRhythm Technologies' average media sentiment score of 1.11 beat Anteris Technologies Global's score of 0.36 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies currently has a consensus target price of $187.38, indicating a potential upside of 64.88%. Anteris Technologies Global has a consensus target price of $16.00, indicating a potential upside of 74.86%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

iRhythm Technologies has a net margin of -3.53% compared to Anteris Technologies Global's net margin of -5,148.78%. iRhythm Technologies' return on equity of -10.26% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Summary

iRhythm Technologies beats Anteris Technologies Global on 10 of the 14 factors compared between the two stocks.

How does Anteris Technologies Global compare to Warby Parker?

Warby Parker (NYSE:WRBY) and Anteris Technologies Global (NASDAQ:AVR) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Warby Parker and Warby Parker both had 5 articles in the media. Anteris Technologies Global's average media sentiment score of 0.36 beat Warby Parker's score of 0.33 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

93.2% of Warby Parker shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Warby Parker has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market.

Warby Parker currently has a consensus price target of $29.50, indicating a potential upside of 12.07%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 74.86%. Given Anteris Technologies Global's higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Warby Parker has a net margin of 0.15% compared to Anteris Technologies Global's net margin of -5,148.78%. Warby Parker's return on equity of 2.30% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Warby Parker has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.23	$1.64M	$0.02	1,316.20
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A

Summary

Warby Parker beats Anteris Technologies Global on 12 of the 15 factors compared between the two stocks.

How does Anteris Technologies Global compare to TransMedics Group?

Anteris Technologies Global (NASDAQ:AVR) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Anteris Technologies Global had 1 more articles in the media than TransMedics Group. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.55 beat Anteris Technologies Global's score of 0.36 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TransMedics Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Anteris Technologies Global presently has a consensus price target of $16.00, indicating a potential upside of 74.86%. TransMedics Group has a consensus price target of $134.00, indicating a potential upside of 83.79%. Given TransMedics Group's higher possible upside, analysts plainly believe TransMedics Group is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

TransMedics Group has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A
TransMedics Group	$605.49M	4.16	$190.29M	$4.40	16.57

TransMedics Group has a net margin of 27.04% compared to Anteris Technologies Global's net margin of -5,148.78%. TransMedics Group's return on equity of 22.38% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
TransMedics Group	27.04%	22.38%	8.46%

99.7% of TransMedics Group shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Anteris Technologies Global has a beta of 1.77, meaning that its share price is 77% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market.

Summary

TransMedics Group beats Anteris Technologies Global on 13 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to AxoGen?

Anteris Technologies Global (NASDAQ:AVR) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

80.3% of AxoGen shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 2.4% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Anteris Technologies Global had 3 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for AxoGen. AxoGen's average media sentiment score of 1.84 beat Anteris Technologies Global's score of 0.36 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AxoGen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Anteris Technologies Global currently has a consensus target price of $16.00, suggesting a potential upside of 74.86%. AxoGen has a consensus target price of $46.50, suggesting a potential upside of 8.14%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Anteris Technologies Global has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

AxoGen has higher revenue and earnings than Anteris Technologies Global. AxoGen is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A
AxoGen	$225.21M	10.15	-$15.70M	-$0.64	N/A

AxoGen has a net margin of -13.21% compared to Anteris Technologies Global's net margin of -5,148.78%. AxoGen's return on equity of -9.63% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
AxoGen	-13.21%	-9.63%	-6.26%

Summary

AxoGen beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Anteris Technologies Global (NASDAQ:AVR) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Establishment Labs has a net margin of -19.05% compared to Anteris Technologies Global's net margin of -5,148.78%. Anteris Technologies Global's return on equity of -124.76% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Establishment Labs has higher revenue and earnings than Anteris Technologies Global. Establishment Labs is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	11.45	-$51.06M	-$1.49	N/A
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A

Establishment Labs has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market.

In the previous week, Anteris Technologies Global had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.94 beat Anteris Technologies Global's score of 0.36 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Establishment Labs presently has a consensus price target of $87.14, indicating a potential upside of 6.09%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 74.86%. Given Anteris Technologies Global's higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

72.9% of Establishment Labs shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Establishment Labs beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVR vs. The Competition

Export

Metric	Anteris Technologies Global	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$890.66M	$7.04B	$6.53B	$12.05B
Dividend Yield	N/A	1.21%	2.67%	5.66%
P/E Ratio	-4.10	47.88	23.99	24.42
Price / Sales	466.31	70.95	513.41	111.24
Price / Cash	N/A	25.59	27.48	37.92
Price / Book	-915.00	6.84	10.73	6.82
Net Income	-$94.14M	$159.20M	$3.57B	$337.56M
7 Day Performance	-2.03%	-0.93%	0.59%	1.17%
1 Month Performance	26.38%	5.15%	1.54%	3.16%
1 Year Performance	108.90%	1.23%	25.42%	30.58%

Anteris Technologies Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVR Anteris Technologies Global	3.6777 of 5 stars	$9.15 flat	$16.00 +74.9%	+108.9%	$890.66M	$1.91M	N/A	138
IRTC iRhythm Technologies	4.3412 of 5 stars	$107.23 -0.8%	$189.69 +76.9%	-21.0%	$3.52B	$787.85M	N/A	2,400	Positive News
WRBY Warby Parker	3.42 of 5 stars	$23.48 +3.3%	$29.50 +25.6%	+19.4%	$2.51B	$890.57M	1,174.49	4,036	Insider Trade
TMDX TransMedics Group	4.4006 of 5 stars	$71.14 +2.5%	$134.00 +88.4%	-49.0%	$2.46B	$635.89M	16.17	210
AXGN AxoGen	2.0214 of 5 stars	$41.46 -3.1%	$46.50 +12.2%	+341.0%	$2.20B	$238.11M	N/A	450

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVR) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Anteris Technologies Global (AVR) Competitors

AVR vs. IRTC, WRBY, TMDX, AXGN, and ESTA

How does Anteris Technologies Global compare to iRhythm Technologies?

Summary

How does Anteris Technologies Global compare to Warby Parker?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Summary

How does Anteris Technologies Global compare to AxoGen?

Summary

How does Anteris Technologies Global compare to Establishment Labs?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Anteris Technologies Global (AVR) Competitors

AVR vs. IRTC, WRBY, TMDX, AXGN, and ESTA

How does Anteris Technologies Global compare to iRhythm Technologies?

Which has preferable valuation & earnings, IRTC or AVR?

Which has more risk and volatility, IRTC or AVR?

Does the media prefer IRTC or AVR?

Do analysts rate IRTC or AVR?

Is IRTC or AVR more profitable?

Summary

How does Anteris Technologies Global compare to Warby Parker?

Does the media favor WRBY or AVR?

Do insiders and institutionals have more ownership in WRBY or AVR?

Which has more risk and volatility, WRBY or AVR?

Do analysts rate WRBY or AVR?

Is WRBY or AVR more profitable?

Which has preferable valuation and earnings, WRBY or AVR?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Does the media refer more to AVR or TMDX?

Do analysts prefer AVR or TMDX?

Which has better valuation & earnings, AVR or TMDX?

Is AVR or TMDX more profitable?

Do insiders & institutionals believe in AVR or TMDX?

Which has more risk and volatility, AVR or TMDX?

Summary

How does Anteris Technologies Global compare to AxoGen?

Do insiders and institutionals have more ownership in AVR or AXGN?

Does the media prefer AVR or AXGN?

Do analysts prefer AVR or AXGN?

Which has more risk & volatility, AVR or AXGN?

Which has preferable valuation & earnings, AVR or AXGN?

Is AVR or AXGN more profitable?

Summary

How does Anteris Technologies Global compare to Establishment Labs?

Is ESTA or AVR more profitable?

Which has stronger earnings and valuation, ESTA or AVR?

Which has more volatility and risk, ESTA or AVR?

Does the media refer more to ESTA or AVR?

Do analysts rate ESTA or AVR?

Do insiders and institutionals have more ownership in ESTA or AVR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools